Drug Interactions between cyclophosphamide and pomalidomide
This report displays the potential drug interactions for the following 2 drugs:
- cyclophosphamide
- pomalidomide
Interactions between your drugs
No interactions were found between cyclophosphamide and pomalidomide. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
cyclophosphamide
A total of 379 drugs are known to interact with cyclophosphamide.
- Cyclophosphamide is in the drug class alkylating agents.
-
Cyclophosphamide is used to treat the following conditions:
- Acute Lymphocytic Leukemia
- Acute Nonlymphocytic Leukemia
- Bladder Cancer (off-label)
- Brain Tumor (off-label)
- Breast Cancer
- Bullous Pemphigoid (off-label)
- Cancer
- Cervical Cancer (off-label)
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Cogan's Syndrome (off-label)
- Dermatomyositis (off-label)
- Diffuse Large B-Cell Lymphoma
- Endometrial Cancer (off-label)
- Ewing's Sarcoma (off-label)
- Granulomatosis with Polyangiitis (off-label)
- Histiocytosis (off-label)
- Hodgkin's Lymphoma
- Lupus (off-label)
- Lupus Nephritis (off-label)
- Mantle Cell Lymphoma
- Multiple Myeloma
- Multiple Sclerosis (off-label)
- Mycosis Fungoides (off-label)
- Nephrotic Syndrome
- Neuroblastoma (off-label)
- Non-Hodgkin's Lymphoma
- Non-Small Cell Lung Cancer (off-label)
- Organ Transplant, Rejection Prophylaxis (off-label)
- Osteosarcoma (off-label)
- Ovarian Cancer
- Pemphigoid (off-label)
- Pemphigus (off-label)
- Primary Immunoglobulin A Nephropathy
- Prostate Cancer (off-label)
- Rheumatoid Arthritis (off-label)
- Scleroderma (off-label)
- Small Cell Lung Cancer (off-label)
- Systemic Sclerosis (off-label)
- Testicular Cancer (off-label)
- Wilms' Tumor (off-label)
pomalidomide
A total of 378 drugs are known to interact with pomalidomide.
- Pomalidomide is in the following drug classes: miscellaneous antineoplastics, other immunosuppressants.
- Pomalidomide is used to treat the following conditions:
Drug and food interactions
pomalidomide food
Applies to: pomalidomide
MONITOR: Cigarette smoking may reduce pomalidomide exposure due to induction of CYP450 1A2, the isoenzyme that is responsible for the metabolic clearance of pomalidomide along with CYP450 3A4.
MANAGEMENT: Patients should be advised that smoking may reduce the efficacy of pomalidomide therapy. Pomalidomide should be taken on an empty stomach, at least 2 hours before or 2 hours after a meal.
References
- "Product Information. Pomalyst (pomalidomide)." QLT Phototherapeutics Inc (2013):
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.